| scholarly article | Q13442814 |
| P2093 | author name string | Weidong Gu | |
| Fujun Zhang | |||
| Buwei Yu | |||
| Zhengwen Ma | |||
| Peihua Lu | |||
| Qingsheng Xue | |||
| P2860 | cites work | Treatment of stroke in rat with intracarotid administration of marrow stromal cells | Q43653449 |
| Fast hematopoietic recovery after bone marrow engraftment needs physiological proximity of stromal and stem cells. | Q52551562 | ||
| P433 | issue | 3 | |
| P921 | main subject | bone marrow | Q546523 |
| mesenchymal stem cell | Q1922379 | ||
| P304 | page(s) | 205-217 | |
| P577 | publication date | 2009-10-21 | |
| P1433 | published in | Neuropathology | Q15761930 |
| P1476 | title | Transplantation of bone marrow mesenchymal stem cells reduces lesion volume and induces axonal regrowth of injured spinal cord | |
| P478 | volume | 30 |
| Q48959185 | Autologous bone marrow cell transplantation in acute spinal cord injury--an Indian pilot study |
| Q58707994 | BMSCs promote the differentiation of NSCs into oligodendrocytes via mediating Id2 and Olig expression through BMP/Smad signaling pathway |
| Q33790302 | Bridging defects in chronic spinal cord injury using peripheral nerve grafts combined with a chitosan-laminin scaffold and enhancing regeneration through them by co-transplantation with bone-marrow-derived mesenchymal stem cells: case series of [...] |
| Q26799335 | Cell Therapy Augments Functional Recovery Subsequent to Spinal Cord Injury under Experimental Conditions |
| Q36635432 | Cell transplantation for spinal cord injury: a systematic review |
| Q39261219 | Cell transplantation therapy for spinal cord injury. |
| Q38119160 | Cell-based therapy for the deficient urinary sphincter |
| Q40485304 | Comparison of Capability of Human Bone Marrow Mesenchymal Stem Cells and Endometrial Stem Cells to Differentiate into Motor Neurons on Electrospun Poly(ε-caprolactone) Scaffold |
| Q34685130 | EZH2 regulates neuronal differentiation of mesenchymal stem cells through PIP5K1C-dependent calcium signaling |
| Q38226668 | Gene therapy strategies for the treatment of spinal cord injury |
| Q38207902 | Grafted bone marrow stromal cells: a contributor to glial repair after spinal cord injury |
| Q58702859 | Improved Bowel Function in Patients with Spina Bifida After Bone Marrow-Derived Mononuclear Cell Transplantation: A Report of 2 Cases |
| Q26753150 | Increased Understanding of Stem Cell Behavior in Neurodegenerative and Neuromuscular Disorders by Use of Noninvasive Cell Imaging |
| Q54318848 | Lithium stimulates human bone marrow derived mesenchymal stem cell proliferation through GSK-3β-dependent β-catenin/Wnt pathway activation. |
| Q87396090 | Mesenchymal stem cell transplantation reduces glial cyst and improves functional outcome after spinal cord compression |
| Q38086083 | Mesenchymal stem cells secretome: a new paradigm for central nervous system regeneration? |
| Q64082916 | Mesenchymal stem cells transplanted into spinal cord injury adopt immune cell-like characteristics |
| Q26799107 | Mesenchymal stem/stromal cells as a delivery platform in cell and gene therapies |
| Q35921652 | Mesenchymal stem/stromal cells-a key mediator for regeneration after perinatal morbidity? |
| Q33587508 | Mesenchymal stromal cells integrate and form longitudinally-aligned layers when delivered to injured spinal cord via a novel fibrin scaffold |
| Q38207603 | Neurotrauma and mesenchymal stem cells treatment: From experimental studies to clinical trials |
| Q27015716 | Progress of mesenchymal stem cell therapy for neural and retinal diseases |
| Q26745909 | Recent advances in managing a spinal cord injury secondary to trauma |
| Q26768645 | Role of Epigenetics in Stem Cell Proliferation and Differentiation: Implications for Treating Neurodegenerative Diseases |
| Q39384582 | Roles of Mesenchymal Stem Cells in Spinal Cord Injury |
| Q48909793 | Significant clinical, neuropathological and behavioural recovery from acute spinal cord trauma by transplantation of a well-defined somatic stem cell from human umbilical cord blood |
| Q36771332 | Smurf2-mediated degradation of EZH2 enhances neuron differentiation and improves functional recovery after ischaemic stroke |
| Q37765474 | Stem cell therapies for spinal cord injury |
| Q86543594 | Stem cell therapy in spinal trauma: Does it have scientific validity? |
| Q34991998 | Stem cells for spine surgery |
| Q35025126 | Stem cells in regenerative medicine |
| Q42376420 | The combined strategy of mesenchymal stem cells and tissue-engineered scaffolds for spinal cord injury regeneration |
| Q33771698 | The stem cell secretome and its role in brain repair |
| Q51313318 | Tips on How to Collect and Administer the Mesenchymal Stem Cell Secretome for Central Nervous System Applications. |
| Q35667215 | Towards a Treatment of Stress Urinary Incontinence: Application of Mesenchymal Stromal Cells for Regeneration of the Sphincter Muscle |
| Q38957847 | Transfection of the glial cell line-derived neurotrophic factor gene promotes neuronal differentiation |
| Q84239768 | Transplantation of predifferentiated adipose-derived stromal cells for the treatment of spinal cord injury |
| Q47215543 | γδ T cells provide the early source of IFN-γ to aggravate lesions in spinal cord injury |
Search more.